nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0795	0.341	CbGeAlD
Pergolide—HTR2B—cardial valve—dilated cardiomyopathy	0.0513	0.22	CbGeAlD
Pergolide—Carcinoma breast—Spironolactone—dilated cardiomyopathy	0.0411	0.0976	CcSEcCtD
Pergolide—KCNH2—endocardium—dilated cardiomyopathy	0.0409	0.176	CbGeAlD
Pergolide—Breast cancer—Spironolactone—dilated cardiomyopathy	0.0152	0.0362	CcSEcCtD
Pergolide—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0111	0.0476	CbGeAlD
Pergolide—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0108	0.0463	CbGeAlD
Pergolide—DRD4—heart—dilated cardiomyopathy	0.00772	0.0331	CbGeAlD
Pergolide—Breast pain—Spironolactone—dilated cardiomyopathy	0.00637	0.0151	CcSEcCtD
Pergolide—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00632	0.015	CcSEcCtD
Pergolide—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.00597	0.0142	CcSEcCtD
Pergolide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00569	0.0135	CcSEcCtD
Pergolide—Cabergoline—ADRB1—dilated cardiomyopathy	0.00566	0.398	CrCbGaD
Pergolide—Cabergoline—ADRB2—dilated cardiomyopathy	0.00476	0.335	CrCbGaD
Pergolide—Bursitis—Lisinopril—dilated cardiomyopathy	0.00469	0.0112	CcSEcCtD
Pergolide—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00469	0.0112	CcSEcCtD
Pergolide—Apathy—Furosemide—dilated cardiomyopathy	0.00423	0.0101	CcSEcCtD
Pergolide—Flat affect—Furosemide—dilated cardiomyopathy	0.00419	0.00997	CcSEcCtD
Pergolide—Blindness—Lisinopril—dilated cardiomyopathy	0.0041	0.00974	CcSEcCtD
Pergolide—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.0039	0.00928	CcSEcCtD
Pergolide—Lisuride—ADRB1—dilated cardiomyopathy	0.00379	0.267	CrCbGaD
Pergolide—Ataxia—Spironolactone—dilated cardiomyopathy	0.00379	0.00902	CcSEcCtD
Pergolide—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00376	0.00894	CcSEcCtD
Pergolide—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00373	0.00886	CcSEcCtD
Pergolide—Gastritis—Spironolactone—dilated cardiomyopathy	0.00357	0.00849	CcSEcCtD
Pergolide—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00353	0.0084	CcSEcCtD
Pergolide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00345	0.0082	CcSEcCtD
Pergolide—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00345	0.0148	CbGeAlD
Pergolide—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.0034	0.0146	CbGeAlD
Pergolide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00326	0.00775	CcSEcCtD
Pergolide—KCNH2—myocardium—dilated cardiomyopathy	0.00324	0.0139	CbGeAlD
Pergolide—Gout—Furosemide—dilated cardiomyopathy	0.00324	0.0077	CcSEcCtD
Pergolide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00321	0.00763	CcSEcCtD
Pergolide—ADRA2C—myocardium—dilated cardiomyopathy	0.0032	0.0137	CbGeAlD
Pergolide—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00315	0.00748	CcSEcCtD
Pergolide—Vasculitis—Furosemide—dilated cardiomyopathy	0.0031	0.00736	CcSEcCtD
Pergolide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00308	0.00732	CcSEcCtD
Pergolide—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00306	0.00728	CcSEcCtD
Pergolide—Renal failure—Spironolactone—dilated cardiomyopathy	0.00306	0.00726	CcSEcCtD
Pergolide—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00301	0.00716	CcSEcCtD
Pergolide—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00296	0.00704	CcSEcCtD
Pergolide—Otitis media—Lisinopril—dilated cardiomyopathy	0.00291	0.00693	CcSEcCtD
Pergolide—HTR2B—heart—dilated cardiomyopathy	0.00284	0.0122	CbGeAlD
Pergolide—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00274	0.0065	CcSEcCtD
Pergolide—Bladder pain—Furosemide—dilated cardiomyopathy	0.00273	0.0065	CcSEcCtD
Pergolide—Mental disability—Furosemide—dilated cardiomyopathy	0.00262	0.00624	CcSEcCtD
Pergolide—Breast pain—Lisinopril—dilated cardiomyopathy	0.0026	0.00618	CcSEcCtD
Pergolide—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00256	0.00609	CcSEcCtD
Pergolide—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00254	0.00603	CcSEcCtD
Pergolide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00252	0.006	CcSEcCtD
Pergolide—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00251	0.00597	CcSEcCtD
Pergolide—Cough increased—Lisinopril—dilated cardiomyopathy	0.00248	0.00589	CcSEcCtD
Pergolide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00247	0.00586	CcSEcCtD
Pergolide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00245	0.00583	CcSEcCtD
Pergolide—Deafness—Furosemide—dilated cardiomyopathy	0.00245	0.00583	CcSEcCtD
Pergolide—Gout—Lisinopril—dilated cardiomyopathy	0.00243	0.00577	CcSEcCtD
Pergolide—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00241	0.00574	CcSEcCtD
Pergolide—ADRA1A—heart—dilated cardiomyopathy	0.00234	0.0101	CbGeAlD
Pergolide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00232	0.00552	CcSEcCtD
Pergolide—Thirst—Furosemide—dilated cardiomyopathy	0.00231	0.00548	CcSEcCtD
Pergolide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0023	0.00546	CcSEcCtD
Pergolide—Neck pain—Lisinopril—dilated cardiomyopathy	0.0023	0.00546	CcSEcCtD
Pergolide—Purpura—Furosemide—dilated cardiomyopathy	0.00228	0.00541	CcSEcCtD
Pergolide—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00227	0.00539	CcSEcCtD
Pergolide—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00227	0.00539	CcSEcCtD
Pergolide—KCNH2—heart—dilated cardiomyopathy	0.00226	0.00971	CbGeAlD
Pergolide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00225	0.00536	CcSEcCtD
Pergolide—ADRA2C—heart—dilated cardiomyopathy	0.00223	0.00958	CbGeAlD
Pergolide—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00222	0.00527	CcSEcCtD
Pergolide—Malaise—Spironolactone—dilated cardiomyopathy	0.00219	0.00521	CcSEcCtD
Pergolide—Cystitis—Lisinopril—dilated cardiomyopathy	0.00219	0.00521	CcSEcCtD
Pergolide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00217	0.00517	CcSEcCtD
Pergolide—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00213	0.00506	CcSEcCtD
Pergolide—Photophobia—Lisinopril—dilated cardiomyopathy	0.00213	0.00506	CcSEcCtD
Pergolide—Urinary retention—Furosemide—dilated cardiomyopathy	0.00209	0.00496	CcSEcCtD
Pergolide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00205	0.00487	CcSEcCtD
Pergolide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00204	0.00486	CcSEcCtD
Pergolide—Dehydration—Furosemide—dilated cardiomyopathy	0.00204	0.00485	CcSEcCtD
Pergolide—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00202	0.0048	CcSEcCtD
Pergolide—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.002	0.00476	CcSEcCtD
Pergolide—Confusional state—Spironolactone—dilated cardiomyopathy	0.002	0.00475	CcSEcCtD
Pergolide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.002	0.00475	CcSEcCtD
Pergolide—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00199	0.00473	CcSEcCtD
Pergolide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00194	0.00461	CcSEcCtD
Pergolide—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00193	0.00831	CbGeAlD
Pergolide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00191	0.00454	CcSEcCtD
Pergolide—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00191	0.0082	CbGeAlD
Pergolide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00189	0.0045	CcSEcCtD
Pergolide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00188	0.00446	CcSEcCtD
Pergolide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00186	0.00442	CcSEcCtD
Pergolide—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00186	0.00442	CcSEcCtD
Pergolide—Eczema—Lisinopril—dilated cardiomyopathy	0.00183	0.00436	CcSEcCtD
Pergolide—Injury—Lisinopril—dilated cardiomyopathy	0.00179	0.00426	CcSEcCtD
Pergolide—ADRA2A—heart—dilated cardiomyopathy	0.00178	0.00765	CbGeAlD
Pergolide—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00178	0.00422	CcSEcCtD
Pergolide—Somnolence—Spironolactone—dilated cardiomyopathy	0.00176	0.00419	CcSEcCtD
Pergolide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00175	0.00416	CcSEcCtD
Pergolide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00174	0.00413	CcSEcCtD
Pergolide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00171	0.00407	CcSEcCtD
Pergolide—Arthritis—Lisinopril—dilated cardiomyopathy	0.00169	0.00403	CcSEcCtD
Pergolide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00169	0.00401	CcSEcCtD
Pergolide—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00168	0.00399	CcSEcCtD
Pergolide—Renal failure—Furosemide—dilated cardiomyopathy	0.00166	0.00395	CcSEcCtD
Pergolide—Diplopia—Lisinopril—dilated cardiomyopathy	0.00165	0.00391	CcSEcCtD
Pergolide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00163	0.00388	CcSEcCtD
Pergolide—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00163	0.00388	CcSEcCtD
Pergolide—Sweating—Furosemide—dilated cardiomyopathy	0.00162	0.00385	CcSEcCtD
Pergolide—Face oedema—Lisinopril—dilated cardiomyopathy	0.00159	0.00378	CcSEcCtD
Pergolide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00157	0.00373	CcSEcCtD
Pergolide—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00157	0.00372	CcSEcCtD
Pergolide—Ataxia—Lisinopril—dilated cardiomyopathy	0.00155	0.00368	CcSEcCtD
Pergolide—Dehydration—Lisinopril—dilated cardiomyopathy	0.00153	0.00364	CcSEcCtD
Pergolide—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00152	0.00654	CbGeAlD
Pergolide—HTR2A—heart—dilated cardiomyopathy	0.00151	0.0065	CbGeAlD
Pergolide—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0015	0.00357	CcSEcCtD
Pergolide—Visual impairment—Furosemide—dilated cardiomyopathy	0.00146	0.00348	CcSEcCtD
Pergolide—Gastritis—Lisinopril—dilated cardiomyopathy	0.00146	0.00346	CcSEcCtD
Pergolide—Influenza—Lisinopril—dilated cardiomyopathy	0.00142	0.00338	CcSEcCtD
Pergolide—Asthma—Lisinopril—dilated cardiomyopathy	0.00142	0.00338	CcSEcCtD
Pergolide—Eye disorder—Furosemide—dilated cardiomyopathy	0.00142	0.00337	CcSEcCtD
Pergolide—Tinnitus—Furosemide—dilated cardiomyopathy	0.00142	0.00336	CcSEcCtD
Pergolide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00141	0.00335	CcSEcCtD
Pergolide—Pruritus—Spironolactone—dilated cardiomyopathy	0.0014	0.00333	CcSEcCtD
Pergolide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.0014	0.00332	CcSEcCtD
Pergolide—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00139	0.0033	CcSEcCtD
Pergolide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00325	CcSEcCtD
Pergolide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00136	0.00322	CcSEcCtD
Pergolide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00136	0.00322	CcSEcCtD
Pergolide—Dysuria—Lisinopril—dilated cardiomyopathy	0.00133	0.00316	CcSEcCtD
Pergolide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00131	0.00312	CcSEcCtD
Pergolide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00131	0.00312	CcSEcCtD
Pergolide—Flatulence—Furosemide—dilated cardiomyopathy	0.0013	0.0031	CcSEcCtD
Pergolide—Weight increased—Lisinopril—dilated cardiomyopathy	0.0013	0.00308	CcSEcCtD
Pergolide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00129	0.00308	CcSEcCtD
Pergolide—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00129	0.00306	CcSEcCtD
Pergolide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00128	0.00305	CcSEcCtD
Pergolide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00128	0.00303	CcSEcCtD
Pergolide—Depression—Lisinopril—dilated cardiomyopathy	0.00127	0.00301	CcSEcCtD
Pergolide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00126	0.003	CcSEcCtD
Pergolide—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00125	0.00297	CcSEcCtD
Pergolide—Rash—Spironolactone—dilated cardiomyopathy	0.00125	0.00297	CcSEcCtD
Pergolide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00125	0.00297	CcSEcCtD
Pergolide—Renal failure—Lisinopril—dilated cardiomyopathy	0.00125	0.00296	CcSEcCtD
Pergolide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00124	0.00296	CcSEcCtD
Pergolide—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00124	0.00296	CcSEcCtD
Pergolide—Headache—Spironolactone—dilated cardiomyopathy	0.00124	0.00295	CcSEcCtD
Pergolide—Jaundice—Lisinopril—dilated cardiomyopathy	0.00124	0.00294	CcSEcCtD
Pergolide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00123	0.00293	CcSEcCtD
Pergolide—Anaemia—Furosemide—dilated cardiomyopathy	0.00122	0.0029	CcSEcCtD
Pergolide—Sweating—Lisinopril—dilated cardiomyopathy	0.00122	0.00289	CcSEcCtD
Pergolide—Agitation—Furosemide—dilated cardiomyopathy	0.00121	0.00289	CcSEcCtD
Pergolide—Haematuria—Lisinopril—dilated cardiomyopathy	0.00121	0.00288	CcSEcCtD
Pergolide—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0012	0.00284	CcSEcCtD
Pergolide—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00283	CcSEcCtD
Pergolide—Vertigo—Furosemide—dilated cardiomyopathy	0.00119	0.00282	CcSEcCtD
Pergolide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00118	0.00281	CcSEcCtD
Pergolide—Nausea—Spironolactone—dilated cardiomyopathy	0.00118	0.0028	CcSEcCtD
Pergolide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00116	0.00276	CcSEcCtD
Pergolide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00114	0.00271	CcSEcCtD
Pergolide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00114	0.00271	CcSEcCtD
Pergolide—Hallucination—Lisinopril—dilated cardiomyopathy	0.00113	0.00269	CcSEcCtD
Pergolide—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00113	0.00269	CcSEcCtD
Pergolide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00112	0.00267	CcSEcCtD
Pergolide—Dry mouth—Furosemide—dilated cardiomyopathy	0.0011	0.00262	CcSEcCtD
Pergolide—Confusional state—Furosemide—dilated cardiomyopathy	0.00109	0.00259	CcSEcCtD
Pergolide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00106	0.00252	CcSEcCtD
Pergolide—Shock—Furosemide—dilated cardiomyopathy	0.00106	0.00252	CcSEcCtD
Pergolide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Pergolide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00104	0.00248	CcSEcCtD
Pergolide—Anorexia—Furosemide—dilated cardiomyopathy	0.00103	0.00244	CcSEcCtD
Pergolide—Chills—Lisinopril—dilated cardiomyopathy	0.00102	0.00243	CcSEcCtD
Pergolide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00102	0.00242	CcSEcCtD
Pergolide—Hypotension—Furosemide—dilated cardiomyopathy	0.00101	0.0024	CcSEcCtD
Pergolide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00101	0.00239	CcSEcCtD
Pergolide—Flatulence—Lisinopril—dilated cardiomyopathy	0.000977	0.00232	CcSEcCtD
Pergolide—Tension—Lisinopril—dilated cardiomyopathy	0.000973	0.00231	CcSEcCtD
Pergolide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000971	0.00231	CcSEcCtD
Pergolide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000969	0.0023	CcSEcCtD
Pergolide—Nervousness—Lisinopril—dilated cardiomyopathy	0.000963	0.00229	CcSEcCtD
Pergolide—Back pain—Lisinopril—dilated cardiomyopathy	0.000959	0.00228	CcSEcCtD
Pergolide—Somnolence—Furosemide—dilated cardiomyopathy	0.000959	0.00228	CcSEcCtD
Pergolide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000938	0.00223	CcSEcCtD
Pergolide—Tremor—Lisinopril—dilated cardiomyopathy	0.000929	0.00221	CcSEcCtD
Pergolide—Constipation—Furosemide—dilated cardiomyopathy	0.000922	0.00219	CcSEcCtD
Pergolide—Pain—Furosemide—dilated cardiomyopathy	0.000922	0.00219	CcSEcCtD
Pergolide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00092	0.00219	CcSEcCtD
Pergolide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000917	0.00218	CcSEcCtD
Pergolide—Malaise—Lisinopril—dilated cardiomyopathy	0.000894	0.00213	CcSEcCtD
Pergolide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000891	0.00212	CcSEcCtD
Pergolide—Syncope—Lisinopril—dilated cardiomyopathy	0.000889	0.00211	CcSEcCtD
Pergolide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000889	0.00211	CcSEcCtD
Pergolide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000888	0.00211	CcSEcCtD
Pergolide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000882	0.0021	CcSEcCtD
Pergolide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000876	0.00208	CcSEcCtD
Pergolide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000872	0.00207	CcSEcCtD
Pergolide—Cough—Lisinopril—dilated cardiomyopathy	0.000865	0.00206	CcSEcCtD
Pergolide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000853	0.00203	CcSEcCtD
Pergolide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000853	0.00203	CcSEcCtD
Pergolide—Myalgia—Lisinopril—dilated cardiomyopathy	0.000844	0.00201	CcSEcCtD
Pergolide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000844	0.00201	CcSEcCtD
Pergolide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000844	0.00201	CcSEcCtD
Pergolide—Anxiety—Lisinopril—dilated cardiomyopathy	0.000841	0.002	CcSEcCtD
Pergolide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000834	0.00198	CcSEcCtD
Pergolide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000826	0.00196	CcSEcCtD
Pergolide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000816	0.00194	CcSEcCtD
Pergolide—Oedema—Lisinopril—dilated cardiomyopathy	0.000809	0.00192	CcSEcCtD
Pergolide—Infection—Lisinopril—dilated cardiomyopathy	0.000804	0.00191	CcSEcCtD
Pergolide—Shock—Lisinopril—dilated cardiomyopathy	0.000796	0.00189	CcSEcCtD
Pergolide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000792	0.00188	CcSEcCtD
Pergolide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00079	0.00188	CcSEcCtD
Pergolide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000782	0.00186	CcSEcCtD
Pergolide—Asthenia—Furosemide—dilated cardiomyopathy	0.000774	0.00184	CcSEcCtD
Pergolide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000771	0.00183	CcSEcCtD
Pergolide—Pruritus—Furosemide—dilated cardiomyopathy	0.000763	0.00181	CcSEcCtD
Pergolide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000756	0.0018	CcSEcCtD
Pergolide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000738	0.00175	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000737	0.00175	CcSEcCtD
Pergolide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000732	0.00174	CcSEcCtD
Pergolide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000727	0.00173	CcSEcCtD
Pergolide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000722	0.00171	CcSEcCtD
Pergolide—Somnolence—Lisinopril—dilated cardiomyopathy	0.000719	0.00171	CcSEcCtD
Pergolide—Dizziness—Furosemide—dilated cardiomyopathy	0.000713	0.0017	CcSEcCtD
Pergolide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000712	0.00169	CcSEcCtD
Pergolide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000704	0.00167	CcSEcCtD
Pergolide—Constipation—Lisinopril—dilated cardiomyopathy	0.000692	0.00164	CcSEcCtD
Pergolide—Pain—Lisinopril—dilated cardiomyopathy	0.000692	0.00164	CcSEcCtD
Pergolide—Vomiting—Furosemide—dilated cardiomyopathy	0.000686	0.00163	CcSEcCtD
Pergolide—Rash—Furosemide—dilated cardiomyopathy	0.00068	0.00162	CcSEcCtD
Pergolide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000679	0.00162	CcSEcCtD
Pergolide—Headache—Furosemide—dilated cardiomyopathy	0.000676	0.00161	CcSEcCtD
Pergolide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000667	0.00159	CcSEcCtD
Pergolide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000662	0.00157	CcSEcCtD
Pergolide—Nausea—Furosemide—dilated cardiomyopathy	0.000641	0.00152	CcSEcCtD
Pergolide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00064	0.00152	CcSEcCtD
Pergolide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00064	0.00152	CcSEcCtD
Pergolide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000581	0.00138	CcSEcCtD
Pergolide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000573	0.00136	CcSEcCtD
Pergolide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000554	0.00132	CcSEcCtD
Pergolide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000535	0.00127	CcSEcCtD
Pergolide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000515	0.00122	CcSEcCtD
Pergolide—Rash—Lisinopril—dilated cardiomyopathy	0.00051	0.00121	CcSEcCtD
Pergolide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00051	0.00121	CcSEcCtD
Pergolide—Headache—Lisinopril—dilated cardiomyopathy	0.000507	0.00121	CcSEcCtD
Pergolide—Nausea—Lisinopril—dilated cardiomyopathy	0.000481	0.00114	CcSEcCtD
Pergolide—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.39e-05	0.000192	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.39e-05	0.000192	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.38e-05	0.000192	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.33e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	6.3e-05	0.00019	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	6.3e-05	0.00019	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.29e-05	0.00019	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.28e-05	0.000189	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.26e-05	0.000189	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.26e-05	0.000188	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.21e-05	0.000187	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.21e-05	0.000187	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.19e-05	0.000186	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.19e-05	0.000186	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.18e-05	0.000186	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.13e-05	0.000185	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.12e-05	0.000184	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.05e-05	0.000182	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.05e-05	0.000182	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.03e-05	0.000182	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.03e-05	0.000181	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.01e-05	0.000181	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.99e-05	0.00018	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.99e-05	0.00018	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.96e-05	0.00018	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.96e-05	0.00018	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.95e-05	0.000179	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.95e-05	0.000179	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	5.94e-05	0.000179	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.93e-05	0.000178	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.86e-05	0.000176	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.85e-05	0.000176	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.83e-05	0.000176	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.82e-05	0.000175	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.8e-05	0.000175	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.8e-05	0.000175	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.77e-05	0.000174	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.76e-05	0.000173	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.75e-05	0.000173	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.74e-05	0.000173	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.72e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.71e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.71e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.71e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	5.69e-05	0.000171	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.68e-05	0.000171	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	5.68e-05	0.000171	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.65e-05	0.00017	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.59e-05	0.000168	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.57e-05	0.000168	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.56e-05	0.000167	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.56e-05	0.000167	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.54e-05	0.000167	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	5.49e-05	0.000165	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.47e-05	0.000165	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.47e-05	0.000165	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	5.46e-05	0.000164	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.45e-05	0.000164	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.4e-05	0.000162	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.39e-05	0.000162	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.39e-05	0.000162	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.37e-05	0.000162	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.36e-05	0.000161	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.35e-05	0.000161	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	5.31e-05	0.00016	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.31e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.31e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.31e-05	0.00016	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.29e-05	0.000159	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.29e-05	0.000159	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.26e-05	0.000158	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.26e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	5.23e-05	0.000157	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.22e-05	0.000157	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.22e-05	0.000157	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	5.22e-05	0.000157	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.18e-05	0.000156	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.18e-05	0.000156	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.14e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.11e-05	0.000154	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.11e-05	0.000154	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.08e-05	0.000153	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.07e-05	0.000153	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.07e-05	0.000153	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.04e-05	0.000152	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.04e-05	0.000152	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.02e-05	0.000151	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.02e-05	0.000151	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5e-05	0.000151	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.97e-05	0.00015	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.96e-05	0.000149	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.93e-05	0.000148	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.92e-05	0.000148	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.89e-05	0.000147	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.86e-05	0.000146	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.85e-05	0.000146	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	4.82e-05	0.000145	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.81e-05	0.000145	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.77e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.75e-05	0.000143	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.74e-05	0.000143	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.74e-05	0.000143	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.71e-05	0.000142	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.71e-05	0.000142	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.71e-05	0.000142	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.7e-05	0.000141	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.66e-05	0.00014	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.64e-05	0.00014	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.63e-05	0.000139	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.61e-05	0.000139	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.59e-05	0.000138	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.57e-05	0.000138	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.56e-05	0.000137	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	4.55e-05	0.000137	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.53e-05	0.000136	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.52e-05	0.000136	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.46e-05	0.000134	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.46e-05	0.000134	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.43e-05	0.000133	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.39e-05	0.000132	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	4.38e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.38e-05	0.000132	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.37e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.37e-05	0.000132	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.37e-05	0.000132	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.37e-05	0.000132	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.35e-05	0.000131	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	4.35e-05	0.000131	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.31e-05	0.00013	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.31e-05	0.00013	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.31e-05	0.00013	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	4.28e-05	0.000129	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	4.26e-05	0.000128	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.24e-05	0.000128	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.23e-05	0.000127	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	4.19e-05	0.000126	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.19e-05	0.000126	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	4.17e-05	0.000125	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.16e-05	0.000125	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.05e-05	0.000122	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	4e-05	0.00012	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.98e-05	0.00012	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.95e-05	0.000119	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.95e-05	0.000119	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.94e-05	0.000119	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.9e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.89e-05	0.000117	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.89e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.89e-05	0.000117	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.84e-05	0.000116	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.81e-05	0.000115	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.79e-05	0.000114	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.78e-05	0.000114	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	3.77e-05	0.000114	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.76e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	3.75e-05	0.000113	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.74e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.72e-05	0.000112	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	3.72e-05	0.000112	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.7e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.69e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.64e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.63e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.62e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.58e-05	0.000108	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.52e-05	0.000106	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.5e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	3.48e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.44e-05	0.000103	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.43e-05	0.000103	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.39e-05	0.000102	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	3.39e-05	0.000102	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	3.38e-05	0.000102	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.38e-05	0.000102	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	3.36e-05	0.000101	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.35e-05	0.000101	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.3e-05	9.93e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.29e-05	9.91e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	3.28e-05	9.89e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.25e-05	9.77e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.24e-05	9.76e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.23e-05	9.73e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	3.23e-05	9.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.22e-05	9.7e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.22e-05	9.7e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.18e-05	9.57e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	3.14e-05	9.45e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	3.09e-05	9.3e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	3.05e-05	9.18e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.04e-05	9.15e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.02e-05	9.08e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	3e-05	9.03e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3e-05	9.03e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.99e-05	9.02e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.98e-05	8.97e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.95e-05	8.9e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.95e-05	8.89e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.93e-05	8.83e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.91e-05	8.75e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.87e-05	8.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	2.85e-05	8.57e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.8e-05	8.44e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.78e-05	8.36e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.74e-05	8.26e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.71e-05	8.15e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.7e-05	8.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.67e-05	8.03e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.62e-05	7.88e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.61e-05	7.87e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.6e-05	7.83e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.58e-05	7.78e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.58e-05	7.78e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.55e-05	7.67e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.53e-05	7.61e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.49e-05	7.49e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.33e-05	7.02e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.29e-05	6.91e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.27e-05	6.82e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.26e-05	6.8e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.25e-05	6.78e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.24e-05	6.74e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.21e-05	6.65e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.21e-05	6.64e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	2.18e-05	6.56e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.14e-05	6.45e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.07e-05	6.23e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.05e-05	6.18e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.03e-05	6.1e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.99e-05	6e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.99e-05	5.98e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.98e-05	5.95e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.94e-05	5.85e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.9e-05	5.73e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.9e-05	5.73e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.79e-05	5.4e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.77e-05	5.33e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.77e-05	5.33e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.77e-05	5.33e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.6e-05	4.81e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.54e-05	4.65e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.54e-05	4.62e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.49e-05	4.5e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.48e-05	4.46e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.47e-05	4.43e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.44e-05	4.34e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.36e-05	4.08e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.33e-05	4.01e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.31e-05	3.93e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.3e-05	3.91e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.21e-05	3.65e-05	CbGpPWpGaD
